Available for oral administration |
Broad-spectrum bactericidal activity (including Gram-positive and Gram-negative bacteria, Mycoplasma/Ureaplasma ssp. and intracellular pathogens) |
Acts as a prodrug |
Antibacterial activity against persisters and pathogens in biofilms |
Class I in the Biopharmaceutical Classification System |
Activity at very low (nanomolar) concentrations |
Accumulation in macrophages |
Useful in hard-to-reach infected sites, e.g., abscesses, central nervous system (CNS), bone tissue |
No teratogenic effects (safe in pregnancy, lactation and childhood) |
Acts on multiple, unrelated, essential bacterial targets |
No drug–drug interactions |
Forms irreversible covalent bonds inside bacterial cells (ruling out drug efflux) |
The drug is excreted from the body unchanged |
|